Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

The osteochondral regeneration paradox: why biomimetic scaffolds are biologically superior but injectable systems dominate the clinic

Gubert S., Moon H., Oliva N., Texidó R.

Narrative Review on Osteoarthritis, Cartilage Damage, published in RSC Adv (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
RSC Adv (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41767232
PMCID
PMC12946866
DOI
10.1039/d5ra09529h
Citations
1

Abstract (original English)

Musculoskeletal disorders (MSDs), particularly articular cartilage injuries and the progression of osteoarthritis (OA), represent a substantial global health burden. Conventional techniques fail to consistently achieve durable regeneration, yielding biomechanically inferior fibrocartilage due to the native tissue's avascularity and complex zonal architecture. This review translates the critical biological, mechanical, and architectural requirements of the osteochondral unit into quantitative design targets and critically evaluates two major regenerative strategies: structurally precise architected biomimetic scaffolds and minimally invasive injectable hydrogels. Our analysis reveals a fundamental trade-off between technical potential and translational feasibility. Architected scaffolds, fabricated using advanced methods like 3D printing and melt electrowriting, demonstrate superior capacity to meet structural demands. They achieve precise zonal stiffness gradients, secure bone anchorage, and immediate high-load-bearing capability necessary for long-term chondrocyte phenotype stabilization and faithful tissue reconstruction. In contrast, injectable hydrogels excel in defect conformability, logistical simplicity, and microenvironmental programming ( e.g. , controlled growth factor release, viscoelastic tuning), offering a patient-friendly, single-stage delivery. However, clinical

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research